Pulse Biosciences Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for Pulse Biosciences.

Analyst Consensus: n/a

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

There are currently no analyst ratings available for Pulse Biosciences.

Recommendation Trends

Rating	Apr '22	May '22	Jun '22	Jul '22	Aug '22
Strong Buy	1	0	0	0	0
Buy	1	1	1	1	1
Hold	0	1	1	1	1
Sell	0	0	0	0	0
Strong Sell	0	0	0	0	0
Total	2	2	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Anthony Vendetti Maxim Group	Maxim Group	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Sep 21, 2022
Swayampakula Ramakanth HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	May 13, 2022
Chris Cooley Stephens & Co.	Stephens & Co.	Buy Maintains $14 → $12	Buy	Maintains	$14 → $12	-33.00%	Apr 1, 2022
Swayampakula Ramakanth HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $20 → $8.5	Strong Buy	Maintains	$20 → $8.5	-52.54%	Apr 1, 2022
Swayampakula Ramakanth HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $43 → $20	Strong Buy	Maintains	$43 → $20	+11.67%	Feb 10, 2022

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

n/a

from -0.92

EPS Next Year

n/a

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024
Revenue	-	1.42M	700.00K	-	-
Revenue Growth	-	-	-50.64%	-	-
EPS	-2.14	-2.28	-1.72	-0.85	-0.92
EPS Growth	-	-	-	-	-
Forward PE	-	-	-	-	-
No. Analysts	-	-	-	-	-

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue
High
Avg
Low

Revenue Growth

Revenue Growth
High
Avg
Low

EPS Forecast

EPS
High
Avg
Low

EPS Growth

EPS Growth
High
Avg
Low

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.